HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hrusková-Heidingsfeldová, O. Articles by Hunter, E. Search for Related Content PubMed PubMed Citation Articles by Hrusková-Heidingsfeldová, O. Articles by Hunter, E. Social Bookmarking                      What's this?

Volume 270, Number 25, Issue of June 23, pp. 15053-15058, 1995
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Olga Hrusková-Heidingsfeldová , Martin Andreansky , Milan Fábry , Ivo Bláha , Petr Strop , Eric Hunter

We have cloned and expressed the 3` region of the Mason-Pfizer monkey virus pro gene in Escherichia coli. The recombinant 26-kDa precursor undergoes rapid self-processing both in E. coli and in vitro at the NH terminus, yielding a proteolytically active 17-kDa protein, p17. This initial cleavage is followed in vitro by a much slower self-processing that leads to emergence of proteolytically active p12 and a COOH-terminal cleavage product p5. We have found the NH-terminal processing site of both the p17 and p12 to be identical and similar to the amino terminus of the mouse mammary tumor virus proteinase. We have also identified the COOH-terminal processing site of the p12 form. Using purified recombinant proteins and synthetic oligopeptide substrates based on naturally occurring retroviral processing sites, we have determined the enzymatic activity and specificity of the Mason-Pfizer monkey virus proteinase to be more closely related to that of myeloblastosis-associated virus proteinase rather than that of the Human immunodeficiency virus type 1 proteinase. Inhibition studies using peptide inhibitors support these results.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				M. S. Mitchell, J. Tozser, G. Princler, P. A. Lloyd, A. Auth, and D. Derse Synthesis, Processing, and Composition of the Virion-associated HTLV-1 Reverse Transcriptase J. Biol. Chem., February 17, 2006; 281(7): 3964 - 3971. [Abstract] [Full Text] [PDF]

				H. Bauerova-Zabranska, J. Stokrova, K. Strisovsky, E. Hunter, T. Ruml, and I. Pichova The RNA Binding G-patch Domain in Retroviral Protease Is Important for Infectivity and D-type Morphogenesis of Mason-Pfizer Monkey Virus J. Biol. Chem., December 23, 2005; 280(51): 42106 - 42112. [Abstract] [Full Text] [PDF]

				R. Gifford, P. Kabat, J. Martin, C. Lynch, and M. Tristem Evolution and Distribution of Class II-Related Endogenous Retroviruses J. Virol., May 15, 2005; 79(10): 6478 - 6486. [Abstract] [Full Text] [PDF]

				O. Barabas, M. Rumlova, A. Erdei, V. Pongracz, I. Pichova, and B. G. Vertessy dUTPase and Nucleocapsid Polypeptides of the Mason-Pfizer Monkey Virus Form a Fusion Protein in the Virion with Homotrimeric Organization and Low Catalytic Efficiency J. Biol. Chem., October 3, 2003; 278(40): 38803 - 38812. [Abstract] [Full Text] [PDF]

				C. Voisset, R. E. Myers, A. Carne, P. Kellam, and D. J. Griffiths Rabbit endogenous retrovirus-H encodes a functional protease J. Gen. Virol., January 1, 2003; 84(1): 215 - 225. [Abstract] [Full Text] [PDF]

				S. D. Parker and E. Hunter Activation of the Mason-Pfizer monkey virus protease within immature capsids invitro PNAS, November 20, 2001; (2001) 251460998. [Abstract] [Full Text] [PDF]

				M. C. Johnson, H. M. Scobie, and V. M. Vogt PR Domain of Rous Sarcoma Virus Gag Causes an Assembly/Budding Defect in Insect Cells J. Virol., May 1, 2001; 75(9): 4407 - 4412. [Abstract] [Full Text]

				J. M. Louis, S. Oroszlan, and J. Tozser Stabilization from Autoproteolysis and Kinetic Characterization of the Human T-cell Leukemia Virus Type 1 Proteinase J. Biol. Chem., March 5, 1999; 274(10): 6660 - 6666. [Abstract] [Full Text] [PDF]

				M. B. Rao, A. M. Tanksale, M. S. Ghatge, and V. V. Deshpande Molecular and Biotechnological Aspects of Microbial Proteases Microbiol. Mol. Biol. Rev., September 1, 1998; 62(3): 597 - 635. [Abstract] [Full Text] [PDF]

				S. D. Parker and E. Hunter Activation of the Mason-Pfizer monkey virus protease within immature capsids invitro PNAS, December 4, 2001; 98(25): 14631 - 14636. [Abstract] [Full Text] [PDF]